Literature DB >> 22783779

Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.

Ken Fitch1.   

Abstract

Athletes have always sought to outperform their competitors and regrettably some have resorted to misuse of drugs or doping to achieve this. Stimulants were taken by the first Olympic athletes to be disqualified in 1972. Although undetectable until 1975, from the 1950s androgenic anabolic steroids were administered for increased strength and power followed in the 1990s by erythropoietin for enhanced endurance. Both are highly effective doping agents. As analytical science validated improved techniques to identify these drugs, Olympic athletes, including many medallists were caught and disqualified. When the International Olympic Committee (IOC) prohibited beta blockers (beneficial in shooting), diuretics (assist weight classified athletes) and glucocorticosteroids, some athletes with genuine medical conditions were denied legitimate medical therapy. To overcome this, in 1992 the IOC introduced a system known now as Therapeutic Use Exemption (TUE). This paper discusses Olympic athletes who have been known to dope at past Games and some medical indications and pitfalls in the TUE process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783779      PMCID: PMC4953490          DOI: 10.7861/clinmedicine.12-3-257

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  14 in total

1.  Detection of anabolic steroids by radioimmunoassay.

Authors:  R V Brooks; R G Firth; N A Sumner
Journal:  Br J Sports Med       Date:  1975-07       Impact factor: 13.800

2.  Urine drug testing in an athlete leads to the diagnosis of unsuspected mediastinal germ cell tumor.

Authors:  Andrew E Newcomb; C Peter Clarke; Cherie Y Chiang; George Jerums
Journal:  J Thorac Cardiovasc Surg       Date:  2006-09       Impact factor: 5.209

Review 3.  Medicine and science in the fight against doping in sport.

Authors:  D H Catlin; K D Fitch; A Ljungqvist
Journal:  J Intern Med       Date:  2008-08       Impact factor: 8.989

Review 4.  Androgenic-anabolic steroids and the Olympic Games.

Authors:  Kenneth D Fitch
Journal:  Asian J Androl       Date:  2008-05       Impact factor: 3.285

5.  Glucocorticoids: a doping agent?

Authors:  Martine Duclos
Journal:  Endocrinol Metab Clin North Am       Date:  2010-03       Impact factor: 4.741

6.  Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: controls and athletes with elevated testosterone/epitestosterone ratios.

Authors:  R Aguilera; T E Chapman; B Starcevic; C K Hatton; D H Catlin
Journal:  Clin Chem       Date:  2001-02       Impact factor: 8.327

Review 7.  Insulin.

Authors:  Mario Thevis; Andreas Thomas; Wilhelm Schänzer
Journal:  Handb Exp Pharmacol       Date:  2010

8.  Short-term glucocorticoid intake improves exercise endurance in healthy recreationally trained women.

Authors:  Bénédicte Le Panse; Rémi Thomasson; Laetitia Jollin; Anne-Marie Lecoq; Virgile Amiot; Nathalie Rieth; Jacques De Ceaurriz; Katia Collomp
Journal:  Eur J Appl Physiol       Date:  2009-08-11       Impact factor: 3.078

9.  Steroid profiles of professional soccer players: an international comparative study.

Authors:  E Strahm; P-E Sottas; C Schweizer; M Saugy; J Dvorak; C Saudan
Journal:  Br J Sports Med       Date:  2009-03-12       Impact factor: 13.800

10.  beta-Blockade used in precision sports: effect on pistol shooting performance.

Authors:  P Kruse; J Ladefoged; U Nielsen; P E Paulev; J P Sørensen
Journal:  J Appl Physiol (1985)       Date:  1986-08
View more
  8 in total

Review 1.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

2.  Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse.

Authors:  Marie M Onakomaiya; Donna M Porter; Joseph G Oberlander; Leslie P Henderson
Journal:  Horm Behav       Date:  2014-04-21       Impact factor: 3.587

Review 3.  The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.

Authors:  L Di Luigi; F Pigozzi; P Sgrò; L Frati; A Di Gianfrancesco; M Cappa
Journal:  J Endocrinol Invest       Date:  2019-11-16       Impact factor: 4.256

4.  Proof of Gene Doping in a Mouse Model with a Human Erythropoietin Gene Transferred Using an Adenoviral Vector.

Authors:  Takehito Sugasawa; Takuro Nakano; Shin-Ichiro Fujita; Yuki Matsumoto; Genki Ishihara; Kai Aoki; Koki Yanazawa; Seiko Ono; Shinsuke Tamai; Lev Manevich; Haruna Ueda; Noriyo Ishibashi; Kenshirou Tamai; Yasuharu Kanki; Yasuko Yoshida; Koichi Watanabe; Tohru Takemasa; Yasushi Kawakami; Kazuhiro Takekoshi
Journal:  Genes (Basel)       Date:  2021-08-16       Impact factor: 4.096

Review 5.  The Daniel K. Inouye College of Pharmacy Scripts: The Tantalizing Toxins of Tantalus, A Brief Review of Select Natural Poisons of O'ahu.

Authors:  H Keahi Mookini Horowitz
Journal:  Hawaii J Health Soc Welf       Date:  2021-07

Review 6.  ADHD and adolescent athletes.

Authors:  Ahsan Nazeer; Miriam Mansour; Kathleen A Gross
Journal:  Front Public Health       Date:  2014-06-17

7.  Effect of pseudoephedrine in sport: a systematic review.

Authors:  Kien V Trinh; Jiin Kim; Amanda Ritsma
Journal:  BMJ Open Sport Exerc Med       Date:  2015-12-21

8.  Synthesis and Characterisation of a Monolithic Imprinted Column Using a Methacrylic Acid Monomer with Porogen Propanol for Atenolol Analysis.

Authors:  Aliya Nur Hasanah; Firdha Senja Maelaningsih; Fadli Apriliandi; Akhmad Sabarudin
Journal:  J Anal Methods Chem       Date:  2020-02-28       Impact factor: 2.193

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.